(Circulation. 1997;95:97-103.)
© 1997 American Heart Association, Inc.
Articles |
C-Reactive Protein Colocalizes With Complement in Human Hearts During Acute Myocardial Infarction
the Departments of Cardiology (W.K.L., C.A.V.), Pathology (H.W.M.N., L.H.J., C.J.L.M.M.), and Internal Medicine (C.E.H.), Free University Hospital, Amsterdam; Central Laboratory of the Netherlands Red Cross Blood Transfusion Service and Laboratory for Experimental and Clinical Immunology, University of Amsterdam (G.J.W., C.E.H.); and the Department of Cardiology, University Hospital Sint Radboud, Nijmegen (F.W.A.V.), Netherlands.
Correspondence to Wim K. Lagrand, Free University Hospital, Department of Cardiology, PO Box 7057, NL 1007 MB Amsterdam, Netherlands. E-mail cardiol@azvu.nl.
Background Rises in circulating C-reactive protein (CRP), the prototypical acute-phase protein in humans, correlate with clinical outcome in patients with myocardial ischemia and infarction. We hypothesized that these correlations might reflect active participation of CRP in the local inflammatory response ensuing in the jeopardized myocardium because on binding to a ligand, CRP is able to activate the classic pathway of complement, and in addition, complement activation has been shown to occur locally in infarcted myocardium.
Methods and Results To verify our hypothesis, we investigated localization of CRP in relation to deposition of complement in tissue specimens of infarcted and healthy heart tissue obtained from 17 patients who had died after acute myocardial infarction. CRP was found to be deposited only in infarcted regions and not in normal-appearing areas of the myocardium, being colocalized with depositions of C4 and C3 activation fragments of the complement system. Deposition of CRP and complement in infarcted myocardium appeared to be time dependent, because it was found in all infarctions except for one of young age (<12 hours old) and two of greater age (>1 year old), whereas another tissue specimen of an infarct <12 hours old showed only moderate but positive staining for both CRP and complement in comparison with older infarctions.
Conclusions We conclude that in humans, CRP may localize in infarcted heart tissue and suggest that this acute-phase protein promotes local complement activation, and hence tissue damage, in acute myocardial infarction.
Key Words: proteins • myocardial infarction • immunohistochemistry • immunology
This article has been cited by other articles:
 |
|
 |
|
  S. Chua, L.-T. Chang, C.-K. Sun, J.-J. Sheu, F.-Y. Lee, A. A. Youssef, C.-H. Yang, C.-J. Wu, and H.-K. Yip Time Courses of Subcellular Signal Transduction and Cellular Apoptosis in Remote Viable Myocardium of Rat Left Ventricles Following Acute Myocardial Infarction: Role of Pharmacomodulation Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2009; 14(2): 104 - 115. [Abstract] [PDF]
|
|
|
|
 |
|
 J. Steinberger, S. R. Daniels, R. H. Eckel, L. Hayman, R. H. Lustig, B. McCrindle, and M. L. Mietus-Snyder Progress and Challenges in Metabolic Syndrome in Children and Adolescents: A Scientific Statement From the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism Circulation, February 3, 2009; 119(4): 628 - 647. [Full Text] [PDF]
|
|
|
|
 |
|
 B. M. Scirica, C. P. Cannon, M. S. Sabatine, P. Jarolim, S. Sloane, N. Rifai, E. Braunwald, D. A. Morrow, and for the PROVE IT-TIMI 22 Investigators Concentrations of C-Reactive Protein and B-Type Natriuretic Peptide 30 Days after Acute Coronary Syndromes Independently Predict Hospitalization for Heart Failure and Cardiovascular Death Clin. Chem., February 1, 2009; 55(2): 265 - 273. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M P V Begieneman, F R W van de Goot, I A C van der Bilt, A V. Noordegraaf, M D Spreeuwenberg, W J Paulus, V W M van Hinsbergh, F C Visser, and H W M Niessen Pulmonary embolism causes endomyocarditis in the human heart Heart, April 1, 2008; 94(4): 450 - 456. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Fattouch, G. Bianco, G. Speziale, R. Sampognaro, C. Lavalle, F. Guccione, P. Dioguardi, and G. Ruvolo Beneficial effects of C1 esterase inhibitor in ST-elevation myocardial infarction in patients who underwent surgical reperfusion: a randomised double-blind study Eur. J. Cardiothorac. Surg., August 1, 2007; 32(2): 326 - 332. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. G O'Neill, D. A Isenberg, and A. Rahman Could antibodies to C-reactive protein link inflammation and cardiovascular disease in patients with systemic lupus erythematosus? Ann Rheum Dis, August 1, 2007; 66(8): 989 - 991. [Full Text] [PDF]
|
|
|
|
 |
|
 M. G. Flynn, B. K. McFarlin, and M. M. Markofski State of the Art Reviews: The Anti-Inflammatory Actions of Exercise Training American Journal of Lifestyle Medicine, May 1, 2007; 1(3): 220 - 235. [Abstract] [PDF]
|
|
|
|
|
|
M. S. Sabatine, D. A. Morrow, K. A. Jablonski, M. M. Rice, J. W. Warnica, M. J. Domanski, J. Hsia, B. J. Gersh, N. Rifai, P. M Ridker, et al. Prognostic Significance of the Centers for Disease Control/American Heart Association High-Sensitivity C-Reactive Protein Cut Points for Cardiovascular and Other Outcomes in Patients With Stable Coronary Artery Disease Circulation, March 27, 2007; 115(12): 1528 - 1536. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. N. Kitsis and I. Jialal Limiting myocardial damage during acute myocardial infarction by inhibiting C-reactive protein. N. Engl. J. Med., August 3, 2006; 355(5): 513 - 515. [Full Text] [PDF]
|
|
|
|
|
|
M. Thielmann, G. Marggraf, M. Neuhauser, J. Forkel, U. Herold, M. Kamler, P. Massoudy, and H. Jakob Administration of C1-esterase inhibitor during emergency coronary artery bypass surgery in acute ST-elevation myocardial infarction. Eur. J. Cardiothorac. Surg., August 1, 2006; 30(2): 285 - 293. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Hemelaar, P. Kenemans, C.G. Schalkwijk, D.D.M. Braat, and M.J. van der Mooren No increase in C-reactive protein levels during intranasal compared to oral hormone therapy in healthy post-menopausal women Hum. Reprod., June 1, 2006; 21(6): 1635 - 1642. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Suleiman, R. Khatib, Y. Agmon, R. Mahamid, M. Boulos, M. Kapeliovich, Y. Levy, R. Beyar, W. Markiewicz, H. Hammerman, et al. Early Inflammation and Risk of Long-Term Development of Heart Failure and Mortality in Survivors of Acute Myocardial Infarction: Predictive Role of C-Reactive Protein J. Am. Coll. Cardiol., March 7, 2006; 47(5): 962 - 968. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. D. G. McGrath, M. C. Brouwer, G. J. Arlaud, M. R. Daha, C. E. Hack, and A. Roos Evidence That Complement Protein C1q Interacts with C-Reactive Protein through Its Globular Head Region. J. Immunol., March 1, 2006; 176(5): 2950 - 2957. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J. Armstrong, D. A. Morrow, and M. S. Sabatine Inflammatory Biomarkers in Acute Coronary Syndromes: Part II: Acute-Phase Reactants and Biomarkers of Endothelial Cell Activation Circulation, February 21, 2006; 113(7): e152 - e155. [Full Text] [PDF]
|
|
|
|
 |
|
 T. Kempf, M. Eden, J. Strelau, M. Naguib, C. Willenbockel, J. Tongers, J. Heineke, D. Kotlarz, J. Xu, J. D. Molkentin, et al. The Transforming Growth Factor-{beta} Superfamily Member Growth-Differentiation Factor-15 Protects the Heart From Ischemia/Reperfusion Injury Circ. Res., February 17, 2006; 98(3): 351 - 360. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Meuwissen, A C van der Wal, H W M Niessen, K T Koch, R J de Winter, C M van der Loos, S Z H Rittersma, S A J Chamuleau, J G P Tijssen, A E Becker, et al. Colocalisation of intraplaque C reactive protein, complement, oxidised low density lipoprotein, and macrophages in stable and unstable angina and acute myocardial infarction J. Clin. Pathol., February 1, 2006; 59(2): 196 - 201. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. J. Krijnen, S. A. G. M. Cillessen, R. Manoe, A. Muller, C. A. Visser, C. J. L. M. Meijer, R. J. P. Musters, C. E. Hack, L. A. Aarden, and H. W. M. Niessen Clusterin: a protective mediator for ischemic cardiomyocytes? Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H2193 - H2202. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Theroux, P. W. Armstrong, K. W. Mahaffey, J. S. Hochman, K. J. Malloy, S. Rollins, J. C. Nicolau, J. Lavoie, T. M. Luong, J. Burchenal, et al. Prognostic significance of blood markers of inflammation in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty and effects of pexelizumab, a C5 inhibitor: a substudy of the COMMA trial Eur. Heart J., October 1, 2005; 26(19): 1964 - 1970. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. C. W. Poland, J.-J. G. Vallejo, H. W. M. Niessen, R. Nijmeyer, J. Calafat, C. E. Hack, B. Van het Hof, and W. Van Dijk Activated human PMN synthesize and release a strongly fucosylated glycoform of {alpha}1-acid glycoprotein, which is transiently deposited in human myocardial infarction J. Leukoc. Biol., August 1, 2005; 78(2): 453 - 461. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Satoh, M. Nakamura, T. Akatsu, Y. Shimoda, I. Segawa, and K. Hiramori C-reactive protein co-expresses with tumor necrosis factor-{alpha} in the myocardium in human dilated cardiomyopathy Eur J Heart Fail, August 1, 2005; 7(5): 748 - 754. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. B. Pepys CRP or not CRP? That Is the Question Arterioscler. Thromb. Vasc. Biol., June 1, 2005; 25(6): 1091 - 1094. [Full Text] [PDF]
|
|
|
|
|
|
K. E. Taylor, J. C. Giddings, and C. W. van den Berg C-Reactive Protein-Induced In Vitro Endothelial Cell Activation Is an Artefact Caused by Azide and Lipopolysaccharide Arterioscler. Thromb. Vasc. Biol., June 1, 2005; 25(6): 1225 - 1230. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Di Napoli, M. Schwaninger, R. Cappelli, E. Ceccarelli, G. Di Gianfilippo, C. Donati, H. C.A. Emsley, S. Forconi, S. J. Hopkins, L. Masotti, et al. Evaluation of C-Reactive Protein Measurement for Assessing the Risk and Prognosis in Ischemic Stroke: A Statement for Health Care Professionals From the CRP Pooling Project Members Stroke, June 1, 2005; 36(6): 1316 - 1329. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P A J Krijnen, C Ciurana, T Cramer, T Hazes, C J L M Meijer, C A Visser, H W M Niessen, and C E Hack IgM colocalises with complement and C reactive protein in infarcted human myocardium J. Clin. Pathol., April 1, 2005; 58(4): 382 - 388. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Maier, L. A. Altwegg, R. Corti, S. Gay, M. Hersberger, F. E. Maly, G. Sutsch, M. Roffi, M. Neidhart, F. R. Eberli, et al. Inflammatory Markers at the Site of Ruptured Plaque in Acute Myocardial Infarction: Locally Increased Interleukin-6 and Serum Amyloid A but Decreased C-Reactive Protein Circulation, March 22, 2005; 111(11): 1355 - 1361. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Latini, A. P. Maggioni, G. Peri, L. Gonzini, D. Lucci, P. Mocarelli, L. Vago, F. Pasqualini, S. Signorini, D. Soldateschi, et al. Prognostic Significance of the Long Pentraxin PTX3 in Acute Myocardial Infarction Circulation, October 19, 2004; 110(16): 2349 - 2354. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Zhang, W. G. Austen Jr., I. Chiu, E. M. Alicot, R. Hung, M. Ma, N. Verna, M. Xu, H. B. Hechtman, F. D. Moore Jr., et al. Identification of a specific self-reactive IgM antibody that initiates intestinal ischemia/reperfusion injury PNAS, March 16, 2004; 101(11): 3886 - 3891. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Jernberg, S. James, B. Lindahl, M. Stridsberg, P. Venge, and L. Wallentin NT-proBNP in unstable coronary artery disease--experiences from the FAST, GUSTO IV and FRISC II trials Eur J Heart Fail, March 15, 2004; 6(3): 319 - 325. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Pickup Inflammation and Activated Innate Immunity in the Pathogenesis of Type 2 Diabetes Diabetes Care, March 1, 2004; 27(3): 813 - 823. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Anzai, T. Yoshikawa, H. Kaneko, Y. Maekawa, S. Iwanaga, Y. Asakura, and S. Ogawa Association Between Serum C-Reactive Protein Elevation and Left Ventricular Thrombus Formation After First Anterior Myocardial Infarction Chest, February 1, 2004; 125(2): 384 - 389. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Jernberg, B. Lindahl, A. Siegbahn, B. Andren, G. Frostfeldt, B. Lagerqvist, M. Stridsberg, P. Venge, and L. Wallentin N-terminal pro-brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery disease J. Am. Coll. Cardiol., December 3, 2003; 42(11): 1909 - 1916. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Nikander, M. Metsa-Heikkila, A. Tiitinen, and O. Ylikorkala Evidence of a Lack of Effect of a Phytoestrogen Regimen on the Levels of C-Reactive Protein, E-Selectin, and Nitrate in Postmenopausal Women J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5180 - 5185. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G.M. Hirschfield and M.B. Pepys C-reactive protein and cardiovascular disease: new insights from an old molecule QJM, November 1, 2003; 96(11): 793 - 807. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. B. Granger, K. W. Mahaffey, W. D. Weaver, P. Theroux, J. S. Hochman, T. G. Filloon, S. Rollins, T. G. Todaro, J. C. Nicolau, W. Ruzyllo, et al. Pexelizumab, an Anti-C5 Complement Antibody, as Adjunctive Therapy to Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction: The COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) Trial Circulation, September 9, 2003; 108(10): 1184 - 1190. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P Jousilahti, V Salomaa, V Rasi, E Vahtera, and T Palosuo Association of markers of systemic inflammation, C reactive protein, serum amyloid A, and fibrinogen, with socioeconomic status J Epidemiol Community Health, September 1, 2003; 57(9): 730 - 733. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Nijmeijer, W. K. Lagrand, Y. T. P. Lubbers, C. A. Visser, C. J. L. M. Meijer, H. W. M. Niessen, and C. E. Hack C-Reactive Protein Activates Complement in Infarcted Human Myocardium Am. J. Pathol., July 1, 2003; 163(1): 269 - 275. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. K. James, P. Armstrong, E. Barnathan, R. Califf, B. Lindahl, A. Siegbahn, M. L. Simoons, E. J. Topol, P. Venge, L. Wallentin, et al. Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: A GUSTO-IV substudy J. Am. Coll. Cardiol., March 19, 2003; 41(6): 916 - 924. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P A J Krijnen, C Meischl, C E Hack, C J L M Meijer, C A Visser, D Roos, and H W M Niessen Increased Nox2 expression in human cardiomyocytes after acute myocardial infarction J. Clin. Pathol., March 1, 2003; 56(3): 194 - 199. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. D. Barrett, J. K. Hennan, R. M. Marks, and B. R. Lucchesi C-Reactive-Protein-Associated Increase in Myocardial Infarct Size After Ischemia/Reperfusion J. Pharmacol. Exp. Ther., December 1, 2002; 303(3): 1007 - 1013. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. de Zwaan, A.H. Kleine, J.H.C. Diris, J.F.C. Glatz, H.J.J. Wellens, P.F.W. Strengers, M. Tissing, C.E. Hack, M.P. van Dieijen-Visser, and W.T. Hermens Continuous 48-h C1-inhibitor treatment, following reperfusion therapy, in patients with acute myocardial infarction Eur. Heart J., November 1, 2002; 23(21): 1670 - 1677. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Kluft, R. Kleemann, and M.P.M. de Maat How best to counteract the enemies? By controlling inflammation in the coronary circulation Eur. Heart J. Suppl., November 1, 2002; 4(suppl_G): G53 - G65. [Abstract] [PDF]
|
|
|
|
 |
|
 U. Ikeda, Y. Maeda, K. Yamamoto, and K. Shimada C-Reactive protein augments inducible nitric oxide synthase expression in cytokine-stimulated cardiac myocytes Cardiovasc Res, October 1, 2002; 56(1): 86 - 92. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Afanasyeva and N. R. Rose Cardiomyopathy Is Linked to Complement Activation Am. J. Pathol., August 1, 2002; 161(2): 351 - 357. [Full Text] [PDF]
|
|
|
|
 |
|
 P. L. McGeer and E. G. McGeer Innate Immunity, Local Inflammation, and Degenerative Disease Sci. Aging Knowl. Environ., July 24, 2002; 2002(29): re3 - 3. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. GENCO, S. OFFENBACHER, and J. BECK Periodontal disease and cardiovascular disease: Epidemiology and possible mechanisms J Am Dent Assoc, June 1, 2002; 133(suppl_1): 14S - 22S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Glurich, S. Grossi, B. Albini, A. Ho, R. Shah, M. Zeid, H. Baumann, R. J. Genco, and E. De Nardin Systemic Inflammation in Cardiovascular and Periodontal Disease: Comparative Study Clin. Vaccine Immunol., March 1, 2002; 9(2): 425 - 432. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Baidoshvili, R Nijmeijer, W K Lagrand, C E Hack, and H W M Niessen Localisation of C reactive protein in infarcted tissue sites of multiple organs during sepsis J. Clin. Pathol., February 1, 2002; 55(2): 152 - 153. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Schindler, R. Senf, and U. Frei Influencing the inflammatory response of haemodialysis patients by cytokine elimination using large-pore membranes Nephrol. Dial. Transplant., January 1, 2002; 17(1): 17 - 19. [Full Text] [PDF]
|
|
|
|
 |
|
 C Szalai, G Fust, J Duba, J Kramer, L Romics, Z Prohaszka, and A Csaszar Association of polymorphisms and allelic combinations in the tumour necrosis factor-{alpha}-complement MHC region with coronary artery disease J. Med. Genet., January 1, 2002; 39(1): 46 - 51. [Full Text] [PDF]
|
|
|
|
|
|
R. Nijmeijer, W. K Lagrand, A. Baidoshvili, Y. T.P Lubbers, W. T. Hermens, C. J.L.M Meijer, C. A Visser, C.E. Hack, and H. W.M Niessen Secretory type II phospholipase A2 binds to ischemic myocardium during myocardial infarction in humans Cardiovasc Res, January 1, 2002; 53(1): 138 - 146. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. P. Manderson, M. C. Pickering, M. Botto, M. J. Walport, and C. R. Parish Continual Low-Level Activation of the Classical Complement Pathway J. Exp. Med., September 10, 2001; 194(6): 747 - 756. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Yasojima, C. Schwab, E. G. McGeer, and P. L. McGeer Complement Components, but Not Complement Inhibitors, Are Upregulated in Atherosclerotic Plaques Arterioscler. Thromb. Vasc. Biol., July 1, 2001; 21(7): 1214 - 1219. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Di Napoli, G. Xi, R. F. Keep, Y. Hua, and J. T. Hoff Systemic Complement Activation in Ischemic Stroke Response Stroke, June 1, 2001; 32 (6): 1443 - 1448. [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. HERZIG, D. M. PURDIE, W. CHANG, A. M. BROWN, C. M. HAWLEY, S. B. CAMPBELL, J. M. STURTEVANT, N. M. ISBEL, D. L. NICOL, and D. W. JOHNSON Is C-Reactive Protein a Useful Predictor of Outcome in Peritoneal Dialysis Patients? J. Am. Soc. Nephrol., April 1, 2001; 12(4): 814 - 821. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Yasojima, C. Schwab, E. G. McGeer, and P. L. McGeer Generation of C-Reactive Protein and Complement Components in Atherosclerotic Plaques Am. J. Pathol., March 1, 2001; 158(3): 1039 - 1051. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. B Pepys and A. Berger The renaissance of C reactive protein BMJ, January 6, 2001; 322(7277): 4 - 5. [Full Text] [PDF]
|
|
|
|
|
|
H W M Niessen, W K Lagrand, H J A M Rensink, C. J L M Meijer, L Aarden, and C E Hack Apolipoprotein H, a new mediator in the inflammatory changes ensuing in jeopardised human myocardium J. Clin. Pathol., November 1, 2000; 53(11): 863 - 867. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. K. Lagrand, C. A. Visser, C. E. Hack, H. W. M. Niessen, R. Nijmeijer, W. Konig, and C. Wanner C-reactive protein and cardiovascular disease: linked by complement? Nephrol. Dial. Transplant., October 1, 2000; 15(10): 1709 - 1710. [Full Text] [PDF]
|
|
|
|
|
|
J.C. Kaski, X. Garcia-Moll, W. K. Lagrand, C. A. Visser, H. W. M. Niessen, C. E. Hack, W. T. Hermens, F. W. A. Verheugt, G.-J. Wolbink, and C. E. Hack C-Reactive Protein as a Clinical Marker of Risk Response Circulation, August 29, 2000; 102 (9): e63 - e64. [Full Text] [PDF]
|
|
|
|
|
|
G. Peri, M. Introna, D. Corradi, G. Iacuitti, S. Signorini, F. Avanzini, F. Pizzetti, A. P. Maggioni, T. Moccetti, M. Metra, et al. PTX3, A Prototypical Long Pentraxin, Is an Early Indicator of Acute Myocardial Infarction in Humans Circulation, August 8, 2000; 102(6): 636 - 641. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. L. McGeer and E. G. McGeer Autotoxicity and Alzheimer Disease Arch Neurol, June 1, 2000; 57(6): 789 - 790. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y Zhu, Y Hojo, U Ikeda, K Shimada;, and G F BAXTER Production of hepatocyte growth factor during acute myocardial infarction Heart, April 1, 2000; 83(4): 450 - 455. [Abstract] [Full Text]
|
|
|
|
 |
|
 C. Caliezi, W. A. Wuillemin, S. Zeerleder, M. Redondo, B. Eisele, and C. E. Hack C1-Esterase Inhibitor: An Anti-Inflammatory Agent and Its Potential Use in the Treatment of Diseases Other Than Hereditary Angioedema Pharmacol. Rev., March 1, 2000; 52(1): 91 - 112. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-P. Stein, C. Mold, and T. W. Du Clos C-Reactive Protein Binding to Murine Leukocytes Requires Fc{gamma} Receptors J. Immunol., February 1, 2000; 164(3): 1514 - 1520. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Griselli, J. Herbert, W.L. Hutchinson, K.M. Taylor, M. Sohail, T. Krausz, and M.B. Pepys C-reactive Protein and Complement Are Important Mediators of Tissue Damage in Acute Myocardial Infarction J. Exp. Med., December 20, 1999; 190(12): 1733 - 1740. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P.M Cleutjens, W.M. Blankesteijn, M. J.A.P Daemen, and J. F.M Smits The infarcted myocardium: Simply dead tissue, or a lively target for therapeutic interventions Cardiovasc Res, November 1, 1999; 44(2): 232 - 241. [Full Text] [PDF]
|
|
|
|
|
|
H. Jarva, T. S. Jokiranta, J. Hellwage, P. F. Zipfel, and S. Meri Regulation of Complement Activation by C-Reactive Protein: Targeting the Complement Inhibitory Activity of Factor H by an Interaction with Short Consensus Repeat Domains 7 and 8-11 J. Immunol., October 1, 1999; 163(7): 3957 - 3962. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. K. Lagrand, C. A. Visser, W. T. Hermens, H. W. M. Niessen, F. W. A. Verheugt, G.-J. Wolbink, and C. E. Hack C-Reactive Protein as a Cardiovascular Risk Factor : More Than an Epiphenomenon? Circulation, July 6, 1999; 100(1): 96 - 102. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.W.M. Niessen, W.K. Lagrand, C.A. Visser, C.J.L.M. Meijer, and C.E. Hack Upregulation of ICAM-1 on cardiomyocytes in jeopardized human myocardium during infarction Cardiovasc Res, March 1, 1999; 41(3): 603 - 610. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Danesh, R. Collins, P. Appleby, and R. Peto Association of Fibrinogen, C-reactive Protein, Albumin, or Leukocyte Count With Coronary Heart Disease: Meta-analyses of Prospective Studies JAMA, May 13, 1998; 279(18): 1477 - 1482. [Abstract] [Full Text] [PDF]
|
|